Article Sidebar

PDF (Tiếng Việt)
Published: 2024-06-20
Abstract Views: 24
Views PDF (Tiếng Việt): 23
DOI: https://doi.org/10.52852/tcncyh.v178i5.2519
Issue
Vol. 178 No. 5 (2024)
Section
Các bài báo
How to Cite
Giang, T. V. ., & Khanh, N. T. M. (2024). 46. Treatment results of HIV-AIDS patients co-infected with COVID-19 at the National Hospital of Tropical Diseases (1/2022 - 6/2023). Journal of Medical Research, 178(5), 403-410. https://doi.org/10.52852/tcncyh.v178i5.2519

46. Treatment results of HIV-AIDS patients co-infected with COVID-19 at the National Hospital of Tropical Diseases (1/2022 - 6/2023)

Tran Van Giang, Ngo Thi Mai Khanh

Main Article Content

Abstract

The study was conducted to describe the results of treatment of HIV/AIDS patients co-infected with COVID-19 at the National Hospital of Tropical Diseases, from January 2022 to June 2023. 97 patients were included in the study. Results: The proportion of patients with severe immunodeficiency (CD4 < 200 cells/mm3) was 81.0%, with mild immunodeficiency (CD4 from 200 - 499) was 15.8%, no impairment immunity (CD4 ≥ 500) was 3.2%. 40.2% of patients were discharged from the hospital, and 41.2% were transferred to another hospital. 15.5% of patients became seriously ill and requested to be discharged home, and 3.1% passed away. The average treatment time was 18 ± 13.1 days.

Article Details

Keywords

COVID-19, HIV/AIDS, treatment results

References

1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China. Nature. 2020; 579(7798):265-269.
2. Tesoriero JM, Swain CE, Pierce JL, et al. 2021. COVID-19 outcomes among persons living with or without diagnosed HIV infection in New York State. JAMA Netw Open. 2021;4(2): e2037069-e2037069.
3. Moradi Y, Soheili M, Dehghanbanadaki H, et al. The Effect of HIV/AIDS Infection on the Clinical Outcomes of COVID-19: A Meta-Analysis. Journal of pharmacy & pharmaceutical sciences: a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques. 2022;25:183-192.
4. Kouhpayeh H, Ansari H. HIV infection and increased risk of COVID-19 mortality: A MetaAnalysis. HIV infection and COVID-19. Eur J Transl Myol. 2021;31(4):10107.
5. Cục Y tế dự phòng, Bộ Y tế. 2018. Hướng dẫn xét nghiệm quốc gia. Ban hành kèm theo Quyết định số 2674/QĐ-BYT, ngày 27 tháng 04 năm 2018 của Bộ trưởng Bộ Y tế. 2018.
6. Bộ Y tế. Hướng dẫn chẩn đoán và điều trị COVID-19. Quyết định số 250/QĐ – BYT, ngày 28/01/2022. 2022.
7. GOV. Ministry of Health of Vietnam. COVID-19 Information. 2023. Available online: https://ncov.moh.gov.vn/ (accessed on 25 January 2023).
8. Huang LJ, Zou B, Yang H, et al. Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes. J. Med. Virol. 2021;93:1449-1458.
9. Fenwick C, Joo V, Jacquier P, et al. T-cell exhaustion in HIV infection. Immunol. Rev. 2019;292:149-163.
10. Moir S, Fauci AS. B-cell responses to HIV infection. Immunol. Rev. 2017;275:33-48.
11. Ceravolo A, Orsi GB, Parodi V, et al. Influenza vaccination in HIV-positive subjects: Latest evidence and future perspective. J. Prev. Med. Hyg. 2013;54. doi: 10.15167/2421-4248/jpmh2013.54.1.363.
12. WHO. SAGE roadmap for prioritizing uses of COVID-19 vaccine in the context of limited supply. https://apps.who.int/iris/rest/ bitstreams/1357250/retrieve (accessed Aug 19, 2021). 2021.
13. Hadi YB, Naqvi SFZ, Kupec JT, et al. Characteristics and outcomes of COVID- 19 in patients with HIV: a multicentre research network study. AIDS. 2020;34:F3-8.
14. Atyeo C, Fischinger S, Zohar T, et al. Distinct Early Serological Signatures Track with SARS-CoV-2 Survival. Immunity. 2020;53:524-532.e4.
15. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet Lond Engl. 2020;395(10223):507-513.